H.Extract

company

About

H.Extract is engaged in development, production and sales of the natural plant extracts.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$5.90M
Industries
Health Care,Health Diagnostics,Pharmaceutical,Service Industry
Founded date
Jul 1, 2010
Number Of Employee
51 - 100
Operating Status
Active

The company is dedicated to the R&D, promotion and sales of pharmaceutical ERP. Currently, as a leading brand of domestic pharmaceutical distribution with the Cloud ERP System, Romens has coverd more than 40 thousand pharmacies in China. The company established the strategic partnership with Tencent Cloud & Wechat Pay in May, 2016. Through the joint efforts, they will fasten the development of medicine distribution industry, especially pharmaceutical wholesale, chain-drugstores and the moblization of unit pharmacy. For the past 14 years, with the advanced technical strength, abundant experience in the management of chain-drugstores and profound insight into the industry, Romens has constantly expanded their target customers, including Harbin Pharmaceutical Group, Hainan Zhangzhongjing Dispensary, Sichuan Derentang and etc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$56.90M
H.Extract has raised a total of $56.90M in funding over 2 rounds. Their latest funding was raised on Jul 20, 2022 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 20, 2022 Series D 1 Yinshan Capital Detail
Sep 26, 2021 Series C $51M 2 Detail
Jul 20, 2018 Series B $5.90M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
5
H.Extract is funded by 5 investors. Yinshan Capital and Qingdao Guiding Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Yinshan Capital Yes Series D
Qingdao Guiding Fund Series C
Aoye Group Series C
Gansu Xuanyuan Pharmaceutical Development Series B
Qingdao Metro Financial Holdings Series B